Thomas A. Kerr

3.4k total citations · 1 hit paper
36 papers, 2.7k citations indexed

About

Thomas A. Kerr is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Thomas A. Kerr has authored 36 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 15 papers in Hepatology and 10 papers in Surgery. Recurrent topics in Thomas A. Kerr's work include Liver Disease Diagnosis and Treatment (13 papers), Hepatitis C virus research (10 papers) and Hepatitis B Virus Studies (7 papers). Thomas A. Kerr is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Hepatitis C virus research (10 papers) and Hepatitis B Virus Studies (7 papers). Thomas A. Kerr collaborates with scholars based in United States, Canada and Australia. Thomas A. Kerr's co-authors include Makoto Makishima, Johan Auwerx, David J. Mangelsdorf, Kristina Schoonjans, Timothy T. Lu, Joyce J. Repa, David W. Russell, Wei Ping Li, Erik Lund and Juro Sakai and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Cell and Gastroenterology.

In The Last Decade

Thomas A. Kerr

33 papers receiving 2.6k citations

Hit Papers

Molecular Basis for Feedback Regulation of Bile Acid Synt... 2000 2026 2008 2017 2000 400 800 1.2k

Peers

Thomas A. Kerr
Thomas A. Kerr
Citations per year, relative to Thomas A. Kerr Thomas A. Kerr (= 1×) peers Haim Shirin

Countries citing papers authored by Thomas A. Kerr

Since Specialization
Citations

This map shows the geographic impact of Thomas A. Kerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Kerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Kerr more than expected).

Fields of papers citing papers by Thomas A. Kerr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Kerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Kerr. The network helps show where Thomas A. Kerr may publish in the future.

Co-authorship network of co-authors of Thomas A. Kerr

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Kerr. A scholar is included among the top collaborators of Thomas A. Kerr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Kerr. Thomas A. Kerr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonn, Matthew, Thomas A. Kerr, Jade Boyd, et al.. (2025). A qualitative study exploring motives for the transition from injecting to smoking drugs in Vancouver, British Columbia. International Journal of Drug Policy. 145. 104982–104982.
3.
Kerr, Thomas A., et al.. (2023). Advances in the management of alcohol-associated liver disease. Gastroenterology report. 12. goae097–goae097. 2 indexed citations
4.
Patel, Madhukar S., Lisa B. VanWagner, William M. Lee, et al.. (2023). Biliary atresia and liver transplantation in the United States: A contemporary analysis. Liver International. 43(10). 2198–2209. 3 indexed citations
5.
Rich, Nicole E., Mobolaji Odewole, Ana Huerta, et al.. (2021). High Neutrophil–Lymphocyte Ratio and Delta Neutrophil–Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer. Digestive Diseases and Sciences. 67(6). 2666–2676. 13 indexed citations
6.
Sanjeevaiah, Aravind, Thomas A. Kerr, & Muhammad Shaalan Beg. (2018). Approach and management of checkpoint inhibitor-related immune hepatitis. Journal of Gastrointestinal Oncology. 9(1). 220–224. 24 indexed citations
7.
Hadland, Scott E., Kora DeBeck, Thomas A. Kerr, et al.. (2014). Prescription opioid injection and risk of hepatitis C in relation to traditional drugs of misuse in a prospective cohort of street youth. BMJ Open. 4(7). e005419–e005419. 33 indexed citations
8.
Kalarickal, Philip L., et al.. (2014). Balloon Aortic Valvuloplasty as a Bridge to Liver Transplantation in Patients With Severe Aortic Stenosis: A Case Series. Transplantation Proceedings. 46(10). 3492–3495. 10 indexed citations
9.
Sayuk, Gregory S., Mauricio Lisker‐Melman, Kevin Korenblat, et al.. (2014). Liver Volume in the Cirrhotic Patient: Does Size Matter?. Digestive Diseases and Sciences. 59(4). 886–891. 16 indexed citations
10.
Xie, Yan, Hitoshi Matsumoto, ILKe Nalbantoglu, et al.. (2013). Intestine-Specific Mttp Deletion Increases the Severity of Experimental Colitis and Leads to Greater Tumor Burden in a Model of Colitis Associated Cancer. PLoS ONE. 8(6). e67819–e67819. 9 indexed citations
11.
Thaker, Ameet I., Mahil Rao, Kumar S. Bishnupuri, et al.. (2013). IDO1 Metabolites Activate β-catenin Signaling to Promote Cancer Cell Proliferation and Colon Tumorigenesis in Mice. Gastroenterology. 145(2). 416–425.e4. 158 indexed citations
12.
North, Carol S., Barry A. Hong, & Thomas A. Kerr. (2012). Hepatitis C and substance use. Current Opinion in Psychiatry. 25(3). 206–212. 6 indexed citations
13.
Kerr, Thomas A., Matthew A. Ciorba, Hitoshi Matsumoto, et al.. (2011). Dextran Sodium Sulfate Inhibition of Real-Time Polymerase Chain Reaction Amplification: A Poly-A Purification Solution. Inflammatory Bowel Diseases. 18(2). 344–348. 44 indexed citations
14.
Kerr, Thomas A., Kevin Korenblat, & Nicholas O. Davidson. (2011). MicroRNAs and liver disease. Translational research. 157(4). 241–252. 83 indexed citations
15.
Xie, Yan, Valérie Blanc, Thomas A. Kerr, et al.. (2009). Decreased Expression of Cholesterol 7α-Hydroxylase and Altered Bile Acid Metabolism in Apobec-1−/− Mice Lead to Increased Gallstone Susceptibility. Journal of Biological Chemistry. 284(25). 16860–16871. 18 indexed citations
16.
Grebely, Jason, Jesse D. Raffa, Ching‐chong Lai, et al.. (2009). Low uptake of treatment for hepatitis C virus infection in a large community‐based study of inner city residents. Journal of Viral Hepatitis. 16(5). 352–358. 147 indexed citations
17.
Kerr, Thomas A., Sreenivasa S. Jonnalagadda, Chandra Prakash, & Riad R. Azar. (2007). Pancreatitis following Olanzapine Therapy: A Report of Three Cases. Case Reports in Gastroenterology. 1(1). 15–20. 20 indexed citations
18.
Kerr, Thomas A., Shigeru Saeki, Manfred Schneider, et al.. (2002). Loss of Nuclear Receptor SHP Impairs but Does Not Eliminate Negative Feedback Regulation of Bile Acid Synthesis. Developmental Cell. 2(6). 713–720. 288 indexed citations
19.
Lu, Timothy T., Makoto Makishima, Joyce J. Repa, et al.. (2000). Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors. Molecular Cell. 6(3). 507–515. 1247 indexed citations breakdown →
20.
Stewart, Colin J.R., et al.. (1996). Immunoglobulin light chain mRNA detected by in situ hybridisation in diagnostic fine needle aspiration cytology specimens.. Journal of Clinical Pathology. 49(9). 749–754. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026